Mills Kenneth T.
SEC CIK 1652824 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| RGNX | REGENXBIO Inc. | Pres, CEO, Dir | 495.9K | — | $5.06M | 37 | 2021-09-13 | 2026-05-29 |
Most active insiders at RGNX, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Ciongoli Gregory Austin | Dir | $949.4K | — |
| 2 | PAKOLA STEVE | Chief Medical Off | — | $940.0K |
| 3 | Simpson Curran | CEO, Dir | — | $339.1K |
| 4 | Malzahn Craig | CTO | — | — |
| 5 | Bennett Jean | Dir | — | — |
| 6 | Chan Mitchell | CFO | — | — |
| 7 | Zachary Jennifer | Dir | — | — |
| 8 | Glucksmann Alexandra | Dir | — | — |
| 9 | Fox Allan M. | Dir | — | — |
| 10 | Mills Kenneth T. | Dir | — | — |
Transactions 37
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-06-02 17:16 | 2026-05-29 | RGNX | REGENXBIO Inc. | Mills Kenneth T. | Dir | A - Grant | $0.00 | +9,807 | 495.9K | +2% | $0 |
| D | 2026-01-29 | 2026-01-27 | RGNX | REGENXBIO Inc. | Mills Kenneth T. | Dir | F - Tax | $13.41 | -221.8K | 486.1K | -31% | -$2.97M |
| D | 2026-01-29 | 2026-01-27 | RGNX | REGENXBIO Inc. | Mills Kenneth T. | Dir | M - OptEx | $13.09 | +225.0K | 707.9K | +47% | +$2.95M |
| D | 2025-06-03 | 2025-05-30 | RGNX | REGENXBIO Inc. | Mills Kenneth T. | Dir | A - Grant | $0.00 | +7,768 | 482.9K | +2% | $0 |
| DT | 2025-05-14 | 2025-05-12 | RGNX | REGENXBIO Inc. | Mills Kenneth T. | Dir | M - OptEx | $3.76 | +20.6K | 495.7K | +4% | +$77.5K |
| DT | 2025-05-14 | 2025-05-12 | RGNX | REGENXBIO Inc. | Mills Kenneth T. | Dir | S - Sale+OE | $7.91 | -20.6K | 475.1K | -4% | -$163.0K |
| D | 2025-03-31 | 2025-03-27 | RGNX | REGENXBIO Inc. | Mills Kenneth T. | Dir | M - OptEx | $3.76 | +30.8K | 475.1K | +7% | +$115.6K |
| D | 2024-08-12 | 2024-08-08 | RGNX | REGENXBIO Inc. | Mills Kenneth T. | Dir | M - OptEx | $0.85 | +36.3K | 444.4K | +9% | +$30.9K |
| DMT | 2024-07-26 | 2024-07-24+ | RGNX | REGENXBIO Inc. | Mills Kenneth T. | Dir | M - OptEx | $3.76 | +27.6K | 420.3K | +7% | +$103.7K |
| DMT | 2024-07-26 | 2024-07-24+ | RGNX | REGENXBIO Inc. | Mills Kenneth T. | Dir | S - Sale+OE | $13.88 | -27.6K | 408.0K | -6% | -$383.0K |
| DMT | 2024-07-18 | 2024-07-16+ | RGNX | REGENXBIO Inc. | Mills Kenneth T. | Dir | M - OptEx | $3.76 | +2,410 | 410.2K | +0.6% | +$9,062 |
| DMT | 2024-07-18 | 2024-07-16+ | RGNX | REGENXBIO Inc. | Mills Kenneth T. | Dir | S - Sale+OE | $13.77 | -2,410 | 408.0K | -0.6% | -$33.2K |
| DT | 2024-05-16 | 2024-05-14 | RGNX | REGENXBIO Inc. | Mills Kenneth T. | Pres, CEO, Dir | M - OptEx | $3.76 | +15.0K | 423.0K | +4% | +$56.4K |
| DT | 2024-05-16 | 2024-05-14 | RGNX | REGENXBIO Inc. | Mills Kenneth T. | Pres, CEO, Dir | S - Sale+OE | $15.81 | -15.0K | 408.0K | -4% | -$237.2K |
| DT | 2024-04-17 | 2024-04-15 | RGNX | REGENXBIO Inc. | Mills Kenneth T. | Pres, CEO, Dir | S - Sale+OE | $18.19 | -15.0K | 408.0K | -4% | -$272.9K |
| DT | 2024-04-17 | 2024-04-15 | RGNX | REGENXBIO Inc. | Mills Kenneth T. | Pres, CEO, Dir | M - OptEx | $3.76 | +15.0K | 423.0K | +4% | +$56.4K |
| DT | 2024-03-18 | 2024-03-14 | RGNX | REGENXBIO Inc. | Mills Kenneth T. | Pres, CEO, Dir | M - OptEx | $3.76 | +15.0K | 423.0K | +4% | +$56.4K |
| DT | 2024-03-18 | 2024-03-14 | RGNX | REGENXBIO Inc. | Mills Kenneth T. | Pres, CEO, Dir | S - Sale+OE | $21.86 | -15.0K | 408.0K | -4% | -$327.9K |
| DT | 2024-02-16 | 2024-02-14 | RGNX | REGENXBIO Inc. | Mills Kenneth T. | Pres, CEO, Dir | M - OptEx | $3.76 | +15.0K | 423.0K | +4% | +$56.4K |
| DMT | 2024-02-16 | 2024-02-14 | RGNX | REGENXBIO Inc. | Mills Kenneth T. | Pres, CEO, Dir | S - Sale+OE | $16.75 | -15.0K | 418.4K | -3% | -$251.3K |
| DT | 2024-01-18 | 2024-01-16 | RGNX | REGENXBIO Inc. | Mills Kenneth T. | Pres, CEO, Dir | M - OptEx | $3.76 | +45.0K | 453.0K | +11% | +$169.2K |
| DT | 2024-01-18 | 2024-01-16 | RGNX | REGENXBIO Inc. | Mills Kenneth T. | Pres, CEO, Dir | S - Sale+OE | $15.18 | -45.0K | 408.0K | -10% | -$683.1K |
| D | 2024-01-04 | 2024-01-02 | RGNX | REGENXBIO Inc. | Mills Kenneth T. | Pres, CEO, Dir | F - Tax | $17.95 | -11.4K | 343.9K | -3% | -$203.9K |
| D | 2024-01-04 | 2024-01-02 | RGNX | REGENXBIO Inc. | Mills Kenneth T. | Pres, CEO, Dir | A - Grant | $0.00 | +64.1K | 408.0K | +19% | $0 |
| DMT | 2023-12-21 | 2023-12-19 | RGNX | REGENXBIO Inc. | Mills Kenneth T. | Pres, CEO, Dir | M - OptEx | $3.66 | +45.0K | 400.3K | +13% | +$164.8K |
| DT | 2023-12-21 | 2023-12-19 | RGNX | REGENXBIO Inc. | Mills Kenneth T. | Pres, CEO, Dir | S - Sale+OE | $19.69 | -45.0K | 355.3K | -11% | -$886.0K |
| D | 2023-01-05 | 2023-01-03 | RGNX | REGENXBIO Inc. | Mills Kenneth T. | Pres, CEO, Dir | A - Grant | $0.00 | +54.8K | 355.3K | +18% | $0 |
| D | 2023-01-05 | 2023-01-03 | RGNX | REGENXBIO Inc. | Mills Kenneth T. | Pres, CEO, Dir | F - Tax | $22.68 | -9,308 | 300.5K | -3% | -$211.1K |
| D | 2022-01-04 | 2022-01-01 | RGNX | REGENXBIO Inc. | Mills Kenneth T. | Pres, CEO, Dir | F - Tax | $32.70 | -3,636 | 274.0K | -1% | -$118.9K |
| D | 2022-01-04 | 2022-01-03 | RGNX | REGENXBIO Inc. | Mills Kenneth T. | Pres, CEO, Dir | A - Grant | $0.00 | +35.8K | 309.8K | +13% | $0 |
| 2021-12-06 | 2021-12-02 | RGNX | REGENXBIO Inc. | Mills Kenneth T. | Pres, CEO, Dir | G - Gift | $0.00 | -3,300 | 277.7K | -1% | $0 | |
| D | 2021-11-10 | 2021-11-08 | RGNX | REGENXBIO Inc. | Mills Kenneth T. | Pres, CEO, Dir | M - OptEx | $3.76 | +1,500 | 282.5K | +0.5% | +$5,640 |
| D | 2021-11-10 | 2021-11-08 | RGNX | REGENXBIO Inc. | Mills Kenneth T. | Pres, CEO, Dir | S - Sale+OE | $40.00 | -1,500 | 281.0K | -0.5% | -$60.0K |
| D | 2021-09-29 | 2021-09-27 | RGNX | REGENXBIO Inc. | Mills Kenneth T. | Pres, CEO, Dir | M - OptEx | $3.76 | +1,500 | 282.5K | +0.5% | +$5,640 |
| D | 2021-09-29 | 2021-09-27 | RGNX | REGENXBIO Inc. | Mills Kenneth T. | Pres, CEO, Dir | S - Sale+OE | $42.19 | -1,500 | 281.0K | -0.5% | -$63.3K |
| DM | 2021-09-15 | 2021-09-13+ | RGNX | REGENXBIO Inc. | Mills Kenneth T. | Pres, CEO, Dir | M - OptEx | $3.62 | +38.0K | 314.1K | +14% | +$137.5K |
| DM | 2021-09-15 | 2021-09-13+ | RGNX | REGENXBIO Inc. | Mills Kenneth T. | Pres, CEO, Dir | S - Sale+OE | $44.71 | -38.0K | 281.0K | -12% | -$1.70M |
Purchase Sale Sale after option exercise All abbreviations